Condition
Lymphoma, Follicular clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Lymphoma, Follicular clinical trials that are recruiting, at sites in 20 countries (most in France (4), United Kingdom (3), Australia (2)). By phase: Phase 1/2 (3), Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 20Countries
Newest Lymphoma, Follicular clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| MK-1045 for follicular lymphoma and diffuse large B-cell lymphoma | Phase 1/2 | Los Angeles, California and 53 other locations | Recruiting | Apr 9, 2026 |
| New therapy dose test for people with prior B-cell cancers | Phase 1 | Duarte, California and 50 other locations | Recruiting | Aug 3, 2025 |
| Comparing bone marrow in patients with follicular lymphoma and healthy controls | — | Rennes | Recruiting | Sep 23, 2024 |
| CAR T Cell Therapy for Resistant B-cell Cancers | Phase 1/2 | Beijing, Beijing Municipality | Recruiting | Jan 19, 2024 |
| Treatment of B-cell malignancies with ALETA-001 | Phase 1/2 | Birmingham and 6 other locations | Recruiting | Sep 21, 2023 |
| Treatment of early relapse follicular lymphoma with mosunetuzumab | Phase 2 | Helsinki and 2 other locations | Recruiting | May 9, 2023 |
| Long-term Fertility After Lymphoma Treatment in Young Women | — | Lille | Recruiting | Nov 15, 2022 |
All recruiting trials (7)
-
MK-1045 for follicular lymphoma and diffuse large B-cell lymphoma
This trial tests MK-1045 in people with follicular lymphoma or diffuse large B-cell lymphoma to see if the treatment is safe and tolerable and whether the cancer shrinks or disappears.
-
New therapy dose test for people with prior B-cell cancers
This early-phase study tests different doses of LY4152199 to see if it is safe and effective for people who have already been treated for certain B-cell lymphomas.
-
Comparing bone marrow in patients with follicular lymphoma and healthy controls
This study looks at the differences in bone marrow cells between people with follicular lymphoma and healthy individuals to better understand what might cause relapses in the disease.
-
CAR T Cell Therapy for Resistant B-cell Cancers
This study is testing a new CAR T cell therapy to see if it can safely help people with tough-to-treat B-cell cancers like leukemia and lymphoma.
-
Treatment of B-cell malignancies with ALETA-001
This study is testing a new treatment called ALETA-001 to see if it can help people with relapsed non-Hodgkin lymphoma who didn't respond well to previous therapies.
-
Treatment of early relapse follicular lymphoma with mosunetuzumab
This study is testing if a new treatment called mosunetuzumab can help adults with follicular lymphoma who have had a relapse within two years feel better and live longer compared to standard treatments.
-
Long-term Fertility After Lymphoma Treatment in Young Women
This observational study follows young women who had lymphoma and chemotherapy to see how their ovarian reserve changes years after treatment.
Related topics
Quick answers
How many Lymphoma, Follicular clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 20 countries. The most sites are in France (4 trials), United Kingdom (3 trials), Australia (2 trials), Canada (2 trials), China (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 3, Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.